6/11/25 16:47 | 6/11/25 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ridloff Elena | MA | D | | M.d | 91 | 20.29 | 0 | 5 | | 0 | D | | | | | | | | | | | | | | |
6/11/25 16:47 | 6/11/25 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ridloff Elena | MA | D | | S.d | -225 | 50.00 | 0 | -5 | -100 | 0 | D | | | | | | | | | | | | | | |
6/3/25 18:30 | 6/3/25 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ridloff Elena | MA | D | | M.d | 332 | 27.67 | 0 | 12 | | 0 | D | | | | | | | | | | | | | | |
6/3/25 18:30 | 6/3/25 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ridloff Elena | MA | D | | S.d | -553 | 46.10 | 0 | -12 | -100 | 0 | D | | | | | | | | | | | | | | |
4/30/21 18:55 | 4/29/21 | ACAD | Acadia Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Ridloff Elena | CA | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 3 | 44 | 11 | D | | | | | | | | | | | | | | |
4/30/21 18:55 | 4/30/21 | ACAD | Acadia Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Ridloff Elena | CA | O | EVP,CFO | S.d | -21 | 20.33 | 0 | -1 | -9 | 11 | D | | | | | | | | | | | | | | |
2/8/21 21:00 | 2/4/21 | ACAD | Acadia Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Ridloff Elena | CA | O | EVP,CFO | S | -104 | 50.61 | 0 | -2 | -20 | 8 | D | | | | | | | | | | | | | | |
1/8/21 19:29 | 1/6/21 | ACAD | Acadia Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Ridloff Elena | CA | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 3 | 231 | 4 | D | | | | | | | | | | | | | | |
1/8/21 19:29 | 1/6/21 | ACAD | Acadia Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Ridloff Elena | CA | O | EVP,CFO | S.d | -54 | 53.34 | 0 | -1 | -21 | 4 | D | | | | | | | | | | | | | | |
10/16/20 15:52 | 10/14/20 | KRON | Kronos Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ridloff Elena | CA | D | | P | 50 | 19.00 | 0 | 3 | New | 3 | D | | | | | | | | | | | | | | |
5/1/20 18:00 | 4/29/20 | ACAD | Acadia Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Ridloff Elena | CA | O | EVP,CFO | M.d | 251 | 18.97 | 0 | 13 | | 2 | D | | | | | | | | | | | | | | |
5/1/20 18:00 | 4/29/20 | ACAD | Acadia Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Ridloff Elena | CA | O | EVP,CFO | S.dm | -559 | 50.59 | 0 | -11 | -83 | 2 | D | | | | | | | | | | | | | | |
12/11/19 18:29 | 12/9/19 | ACAD | Acadia Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Ridloff Elena | CA | O | EVP,CFO | M.d | 569 | 15.81 | 0 | 36 | | 0 | D | | | | | | | | | | | | | | |
12/11/19 18:29 | 12/9/19 | ACAD | Acadia Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Ridloff Elena | CA | O | EVP,CFO | S.d | -1,788 | 49.66 | 0 | -36 | -100 | 0 | D | | | | | | | | | | | | | | |